A Study to Compare PK, PD and Safety of the AD-206 and Esomeprazole

NCT03980756 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

88

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastritis

Interventions

DRUG: AD-206 20mg
DRUG: Esomeprazole 20mg
DRUG: AD-206 40mg
DRUG: Esomeprazole 40mg

Sponsor

Addpharma Inc.